Protalix Holds Pre-NDA Meeting with FDA for prGCD

News   Jul 15, 2009

 
Protalix Holds Pre-NDA Meeting with FDA for prGCD
 
 
 

RELATED ARTICLES

Metrohm USA Opens Its New Headquarters in Florida

News

Metrohm USA welcomes its Tampa employees to their new North American headquarters in Riverview, Florida.

READ MORE

Synaptic Proteins May Be Starting Point for Dementia Treatment

News

A new study has identified key proteins, located at the brain's synaptic connections, which may be viable targets for dementia treatment.

READ MORE

Researchers Develop Novel ‘One-pot’ Approach to Conjugated Tetraenes Synthesis

News

TUAT researchers have achieved the new synthetic route of conjugated tetraenes from inexpensive and easily available 1,3-butadiene and substituted acetylenes by a one-pot approach under mild conditions. Conjugated tetraenes are important key substructures in biologically active natural products such as vitamins, and anti-mycotic drugs.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE